HEADER TRANSFERASE 14-SEP-15 5AP0 TITLE NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO TITLE 2 KINASE INHIBITOR DRUG RESISTANCE. COMPND MOL_ID: 1; COMPND 2 MOLECULE: DUAL SPECIFICITY PROTEIN KINASE TTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, UNP RESIDUES 519-808; COMPND 5 SYNONYM: PHOSPHOTYROSINE PICKED THREONINE-PROTEIN KINASE, PYT, COMPND 6 MONOPOLAR SPINDLE KINASE 1; COMPND 7 EC: 2.7.12.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: AI KEYWDS TRANSFERASE, MPS1, PROTEIN KINASE, MITOSIS, DRUG RESISTANCE EXPDTA X-RAY DIFFRACTION AUTHOR M.D.GURDEN,I.M.WESTWOOD,A.FAISAL,S.NAUD,K.J.CHEUNG,C.MCANDREW,A.WOOD, AUTHOR 2 J.SCHMITT,K.BOXALL,G.MAK,P.WORKMAN,R.BURKE,S.HOELDER,J.BLAGG, AUTHOR 3 R.L.M.VAN MONTFORT,S.LINARDOPOULOS REVDAT 3 16-OCT-24 5AP0 1 REMARK REVDAT 2 10-JAN-24 5AP0 1 REMARK LINK REVDAT 1 23-SEP-15 5AP0 0 JRNL AUTH M.D.GURDEN,I.M.WESTWOOD,A.FAISAL,S.NAUD,K.J.CHEUNG, JRNL AUTH 2 C.MCANDREW,A.WOOD,J.SCHMITT,K.BOXALL,G.MAK,P.WORKMAN, JRNL AUTH 3 R.BURKE,S.HOELDER,J.BLAGG,R.L.M.VAN MONTFORT,S.LINARDOPOULOS JRNL TITL NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE JRNL TITL 2 CELLS TO KINASE INHIBITOR DRUG RESISTANCE. JRNL REF CANCER RES. V. 75 3340 2015 JRNL REFN ISSN 0008-5472 JRNL PMID 26202014 JRNL DOI 10.1158/0008-5472.CAN-14-3272 REMARK 2 REMARK 2 RESOLUTION. 2.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.4 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.12 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 23673 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.184 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.090 REMARK 3 FREE R VALUE TEST SET COUNT : 1206 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 12 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.15 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.25 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.17 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2155 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2421 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2050 REMARK 3 BIN R VALUE (WORKING SET) : 0.2428 REMARK 3 BIN FREE R VALUE : 0.2286 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.87 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 105 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2025 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 135 REMARK 3 SOLVENT ATOMS : 59 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 58.67 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 74.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.28750 REMARK 3 B22 (A**2) : -1.90080 REMARK 3 B33 (A**2) : -0.38670 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.306 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.155 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.145 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.155 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.147 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.951 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2191 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2934 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 768 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 56 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 317 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2191 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 279 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2551 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.98 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.40 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: {A|515 - 561} REMARK 3 ORIGIN FOR THE GROUP (A): -10.1026 8.8858 -20.8115 REMARK 3 T TENSOR REMARK 3 T11: -0.2630 T22: -0.2402 REMARK 3 T33: 0.3028 T12: -0.0231 REMARK 3 T13: -0.0417 T23: 0.1520 REMARK 3 L TENSOR REMARK 3 L11: 7.5040 L22: 6.5155 REMARK 3 L33: 3.5529 L12: -2.4152 REMARK 3 L13: -0.1942 L23: -1.6268 REMARK 3 S TENSOR REMARK 3 S11: 0.0619 S12: -0.5442 S13: -0.5442 REMARK 3 S21: 0.1226 S22: 0.1970 S23: 0.3219 REMARK 3 S31: 0.5442 S32: -0.4598 S33: -0.2589 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: {A|562 - 620} REMARK 3 ORIGIN FOR THE GROUP (A): -2.7519 18.6514 -22.6332 REMARK 3 T TENSOR REMARK 3 T11: -0.1952 T22: -0.1860 REMARK 3 T33: 0.1823 T12: 0.0268 REMARK 3 T13: 0.0089 T23: 0.0669 REMARK 3 L TENSOR REMARK 3 L11: 6.4896 L22: 3.1412 REMARK 3 L33: 1.3625 L12: 1.3232 REMARK 3 L13: 1.3955 L23: -1.0481 REMARK 3 S TENSOR REMARK 3 S11: -0.0243 S12: -0.2682 S13: -0.2243 REMARK 3 S21: 0.1135 S22: 0.0971 S23: 0.0636 REMARK 3 S31: 0.0956 S32: -0.0550 S33: -0.0728 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: {A|621 - 712} REMARK 3 ORIGIN FOR THE GROUP (A): 7.2901 25.8780 -17.5318 REMARK 3 T TENSOR REMARK 3 T11: -0.2608 T22: -0.1920 REMARK 3 T33: 0.1612 T12: -0.0217 REMARK 3 T13: 0.0130 T23: 0.1075 REMARK 3 L TENSOR REMARK 3 L11: 5.5099 L22: 3.6172 REMARK 3 L33: 3.3679 L12: 0.5397 REMARK 3 L13: 1.1491 L23: -1.0823 REMARK 3 S TENSOR REMARK 3 S11: -0.0247 S12: -0.2668 S13: -0.1061 REMARK 3 S21: 0.1940 S22: -0.1032 S23: 0.1716 REMARK 3 S31: -0.1322 S32: -0.0180 S33: 0.1279 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: {A|713 - 794} REMARK 3 ORIGIN FOR THE GROUP (A): 16.6672 32.1091 -10.2484 REMARK 3 T TENSOR REMARK 3 T11: -0.2461 T22: -0.0947 REMARK 3 T33: 0.2048 T12: -0.1323 REMARK 3 T13: -0.1095 T23: 0.0695 REMARK 3 L TENSOR REMARK 3 L11: 2.1355 L22: 2.4427 REMARK 3 L33: 4.6152 L12: -0.3316 REMARK 3 L13: -1.2095 L23: -1.1740 REMARK 3 S TENSOR REMARK 3 S11: 0.0372 S12: -0.5442 S13: 0.2400 REMARK 3 S21: 0.5212 S22: -0.2858 S23: -0.4091 REMARK 3 S31: -0.4483 S32: 0.5197 S33: 0.2486 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5AP0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 14-SEP-15. REMARK 100 THE DEPOSITION ID IS D_1290065025. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9793 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : QUANTUM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23736 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.150 REMARK 200 RESOLUTION RANGE LOW (A) : 41.120 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.22 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.70000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4C4J REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.34 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% (V/V) PEG300, PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 35.46500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 55.98000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 56.54500 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 35.46500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 55.98000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 56.54500 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 35.46500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 55.98000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 56.54500 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 35.46500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 55.98000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 56.54500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2005 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 496 REMARK 465 HIS A 497 REMARK 465 HIS A 498 REMARK 465 HIS A 499 REMARK 465 HIS A 500 REMARK 465 HIS A 501 REMARK 465 HIS A 502 REMARK 465 SER A 503 REMARK 465 SER A 504 REMARK 465 GLY A 505 REMARK 465 VAL A 506 REMARK 465 ASP A 507 REMARK 465 LEU A 508 REMARK 465 GLY A 509 REMARK 465 THR A 510 REMARK 465 GLU A 511 REMARK 465 ASN A 512 REMARK 465 LEU A 513 REMARK 465 TYR A 514 REMARK 465 GLN A 670 REMARK 465 MET A 671 REMARK 465 GLN A 672 REMARK 465 PRO A 673 REMARK 465 ASP A 674 REMARK 465 THR A 675 REMARK 465 THR A 676 REMARK 465 SER A 677 REMARK 465 VAL A 678 REMARK 465 VAL A 679 REMARK 465 LYS A 680 REMARK 465 ASP A 681 REMARK 465 SER A 682 REMARK 465 SER A 699 REMARK 465 SER A 700 REMARK 465 SER A 701 REMARK 465 ARG A 702 REMARK 465 GLU A 703 REMARK 465 ASN A 704 REMARK 465 GLY A 705 REMARK 465 LYS A 706 REMARK 465 SER A 707 REMARK 465 LYS A 708 REMARK 465 SER A 709 REMARK 465 LYS A 710 REMARK 465 HIS A 796 REMARK 465 PRO A 797 REMARK 465 VAL A 798 REMARK 465 ASN A 799 REMARK 465 GLN A 800 REMARK 465 MET A 801 REMARK 465 ALA A 802 REMARK 465 LYS A 803 REMARK 465 GLY A 804 REMARK 465 THR A 805 REMARK 465 THR A 806 REMARK 465 GLU A 807 REMARK 465 GLU A 808 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 PHE A 515 CG CD1 CD2 CE1 CE2 CZ REMARK 470 GLN A 516 CG CD OE1 NE2 REMARK 470 LYS A 529 CE NZ REMARK 470 SER A 533 OG REMARK 470 SER A 536 OG REMARK 470 LYS A 538 CD CE NZ REMARK 470 LYS A 546 CG CD CE NZ REMARK 470 LYS A 547 CE NZ REMARK 470 GLU A 559 CG CD OE1 OE2 REMARK 470 GLN A 563 CD OE1 NE2 REMARK 470 LYS A 577 CE NZ REMARK 470 LYS A 614 CE NZ REMARK 470 LYS A 615 CG CD CE NZ REMARK 470 LYS A 616 CD CE NZ REMARK 470 LYS A 617 CG CD CE NZ REMARK 470 SER A 618 OG REMARK 470 VAL A 684 CG1 CG2 REMARK 470 LYS A 696 CE NZ REMARK 470 ILE A 711 CG1 CG2 CD1 REMARK 470 GLU A 753 CD OE1 OE2 REMARK 470 GLU A 755 CG CD OE1 OE2 REMARK 470 LYS A 762 CD CE NZ REMARK 470 LYS A 777 CD CE NZ REMARK 470 THR A 795 CA C O CB OG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 536 17.67 59.46 REMARK 500 LYS A 617 -74.41 -77.01 REMARK 500 SER A 646 -3.97 72.58 REMARK 500 LEU A 772 39.38 -96.86 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 2-(2-(2-(2-(2-(2-ETHOXYETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHOXY)ETHANOL (7 REMARK 600 9-CYCLOPENTYL-2-[[2-METHOXY-4-[(1-METHYLPIPERIDIN-4-YL)OXY]-PHENYL]A REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 P4C A 1797 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AU5 A 1795 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P4C A 1796 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE P4C A 1797 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 1798 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMS A 1799 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1801 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1802 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1803 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1804 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1805 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1806 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1807 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1808 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1809 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1810 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1811 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 1812 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5AP1 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 900 RELATED ID: 5AP2 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 900 RELATED ID: 5AP3 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 900 RELATED ID: 5AP4 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 900 RELATED ID: 5AP5 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 900 RELATED ID: 5AP6 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 900 RELATED ID: 5AP7 RELATED DB: PDB REMARK 900 NATURALLY OCCURRING MUTATIONS IN THE MPS1 GENE PREDISPOSE CELLS TO REMARK 900 KINASE INHIBITOR DRUG RESISTANCE. REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE SEQUENCE INCLUDING HEXAHISTIDINE TAG IS AS DESCRIBED REMARK 999 IN NAT. CHEM. BIOL. 2010, 6, 259-368. DBREF 5AP0 A 519 808 UNP P33981 TTK_HUMAN 519 808 SEQADV 5AP0 MET A 496 UNP P33981 EXPRESSION TAG SEQADV 5AP0 HIS A 497 UNP P33981 EXPRESSION TAG SEQADV 5AP0 HIS A 498 UNP P33981 EXPRESSION TAG SEQADV 5AP0 HIS A 499 UNP P33981 EXPRESSION TAG SEQADV 5AP0 HIS A 500 UNP P33981 EXPRESSION TAG SEQADV 5AP0 HIS A 501 UNP P33981 EXPRESSION TAG SEQADV 5AP0 HIS A 502 UNP P33981 EXPRESSION TAG SEQADV 5AP0 SER A 503 UNP P33981 EXPRESSION TAG SEQADV 5AP0 SER A 504 UNP P33981 EXPRESSION TAG SEQADV 5AP0 GLY A 505 UNP P33981 EXPRESSION TAG SEQADV 5AP0 VAL A 506 UNP P33981 EXPRESSION TAG SEQADV 5AP0 ASP A 507 UNP P33981 EXPRESSION TAG SEQADV 5AP0 LEU A 508 UNP P33981 EXPRESSION TAG SEQADV 5AP0 GLY A 509 UNP P33981 EXPRESSION TAG SEQADV 5AP0 THR A 510 UNP P33981 EXPRESSION TAG SEQADV 5AP0 GLU A 511 UNP P33981 EXPRESSION TAG SEQADV 5AP0 ASN A 512 UNP P33981 EXPRESSION TAG SEQADV 5AP0 LEU A 513 UNP P33981 EXPRESSION TAG SEQADV 5AP0 TYR A 514 UNP P33981 EXPRESSION TAG SEQADV 5AP0 PHE A 515 UNP P33981 EXPRESSION TAG SEQADV 5AP0 GLN A 516 UNP P33981 EXPRESSION TAG SEQADV 5AP0 SER A 517 UNP P33981 EXPRESSION TAG SEQADV 5AP0 MET A 518 UNP P33981 EXPRESSION TAG SEQRES 1 A 313 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 313 GLY THR GLU ASN LEU TYR PHE GLN SER MET SER VAL LYS SEQRES 3 A 313 GLY ARG ILE TYR SER ILE LEU LYS GLN ILE GLY SER GLY SEQRES 4 A 313 GLY SER SER LYS VAL PHE GLN VAL LEU ASN GLU LYS LYS SEQRES 5 A 313 GLN ILE TYR ALA ILE LYS TYR VAL ASN LEU GLU GLU ALA SEQRES 6 A 313 ASP ASN GLN THR LEU ASP SER TYR ARG ASN GLU ILE ALA SEQRES 7 A 313 TYR LEU ASN LYS LEU GLN GLN HIS SER ASP LYS ILE ILE SEQRES 8 A 313 ARG LEU TYR ASP TYR GLU ILE THR ASP GLN TYR ILE TYR SEQRES 9 A 313 MET VAL MET GLU CYS GLY ASN ILE ASP LEU ASN SER TRP SEQRES 10 A 313 LEU LYS LYS LYS LYS SER ILE ASP PRO TRP GLU ARG LYS SEQRES 11 A 313 SER TYR TRP LYS ASN MET LEU GLU ALA VAL HIS THR ILE SEQRES 12 A 313 HIS GLN HIS GLY ILE VAL HIS SER ASP LEU LYS PRO ALA SEQRES 13 A 313 ASN PHE LEU ILE VAL ASP GLY MET LEU LYS LEU ILE ASP SEQRES 14 A 313 PHE GLY ILE ALA ASN GLN MET GLN PRO ASP THR THR SER SEQRES 15 A 313 VAL VAL LYS ASP SER GLN VAL GLY TPO VAL ASN TYR MET SEQRES 16 A 313 PRO PRO GLU ALA ILE LYS ASP MET SER SER SER ARG GLU SEQRES 17 A 313 ASN GLY LYS SER LYS SER LYS ILE SER PRO LYS SER ASP SEQRES 18 A 313 VAL TRP SER LEU GLY CYS ILE LEU TYR TYR MET THR TYR SEQRES 19 A 313 GLY LYS THR PRO PHE GLN GLN ILE ILE ASN GLN ILE SER SEQRES 20 A 313 LYS LEU HIS ALA ILE ILE ASP PRO ASN HIS GLU ILE GLU SEQRES 21 A 313 PHE PRO ASP ILE PRO GLU LYS ASP LEU GLN ASP VAL LEU SEQRES 22 A 313 LYS CYS CYS LEU LYS ARG ASP PRO LYS GLN ARG ILE SER SEQRES 23 A 313 ILE PRO GLU LEU LEU ALA HIS PRO TYR VAL GLN ILE GLN SEQRES 24 A 313 THR HIS PRO VAL ASN GLN MET ALA LYS GLY THR THR GLU SEQRES 25 A 313 GLU MODRES 5AP0 TPO A 686 THR PHOSPHOTHREONINE HET TPO A 686 11 HET AU5 A1795 33 HET P4C A1796 22 HET P4C A1797 16 HET DMS A1798 4 HET DMS A1799 4 HET EDO A1800 4 HET EDO A1801 4 HET EDO A1802 4 HET EDO A1803 4 HET EDO A1804 4 HET EDO A1805 4 HET EDO A1806 4 HET EDO A1807 4 HET EDO A1808 4 HET EDO A1809 4 HET EDO A1810 4 HET EDO A1811 4 HET EDO A1812 4 HET DMS A1813 4 HETNAM TPO PHOSPHOTHREONINE HETNAM AU5 9-CYCLOPENTYL-2-[[2-METHOXY-4-[(1-METHYLPIPERIDIN-4- HETNAM 2 AU5 YL)OXY]-PHENYL]AMINO]-7-METHYL-7,9-DIHYDRO-8H-PURIN-8- HETNAM 3 AU5 ONE HETNAM P4C O-ACETALDEHYDYL-HEXAETHYLENE GLYCOL HETNAM DMS DIMETHYL SULFOXIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN TPO PHOSPHONOTHREONINE HETSYN P4C POLYETHYLENE 400 HETSYN EDO ETHYLENE GLYCOL FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 AU5 C24 H32 N6 O3 FORMUL 3 P4C 2(C14 H28 O8) FORMUL 5 DMS 3(C2 H6 O S) FORMUL 7 EDO 13(C2 H6 O2) FORMUL 21 HOH *59(H2 O) HELIX 1 1 ASP A 561 GLN A 579 1 19 HELIX 2 2 LEU A 609 LYS A 616 1 8 HELIX 3 3 ASP A 620 GLN A 640 1 21 HELIX 4 4 LYS A 649 ALA A 651 5 3 HELIX 5 5 PRO A 691 MET A 698 1 8 HELIX 6 6 SER A 712 GLY A 730 1 19 HELIX 7 7 ASN A 739 ASP A 749 1 11 HELIX 8 8 GLU A 761 LEU A 772 1 12 HELIX 9 9 SER A 781 ALA A 787 1 7 HELIX 10 10 HIS A 788 ILE A 793 1 6 SHEET 1 AA 6 SER A 517 VAL A 520 0 SHEET 2 AA 6 ARG A 523 SER A 533 -1 O ARG A 523 N VAL A 520 SHEET 3 AA 6 SER A 537 LEU A 543 -1 O VAL A 539 N ILE A 531 SHEET 4 AA 6 ILE A 549 ASN A 556 -1 O TYR A 550 N VAL A 542 SHEET 5 AA 6 TYR A 597 MET A 602 -1 O ILE A 598 N VAL A 555 SHEET 6 AA 6 LEU A 588 ILE A 593 -1 N TYR A 589 O VAL A 601 SHEET 1 AB 3 ILE A 607 ASP A 608 0 SHEET 2 AB 3 PHE A 653 VAL A 656 -1 N ILE A 655 O ILE A 607 SHEET 3 AB 3 MET A 659 LEU A 662 -1 O MET A 659 N VAL A 656 LINK C GLY A 685 N TPO A 686 1555 1555 1.36 LINK C TPO A 686 N VAL A 687 1555 1555 1.34 SITE 1 AC1 15 ILE A 531 VAL A 539 ALA A 551 ILE A 586 SITE 2 AC1 15 MET A 602 GLU A 603 CYS A 604 GLY A 605 SITE 3 AC1 15 ASN A 606 ILE A 607 ASP A 608 SER A 611 SITE 4 AC1 15 LEU A 654 P4C A1796 DMS A1798 SITE 1 AC2 10 SER A 537 VAL A 539 LYS A 553 TYR A 568 SITE 2 AC2 10 GLU A 571 MET A 600 MET A 602 ILE A 663 SITE 3 AC2 10 AU5 A1795 HOH A2012 SITE 1 AC3 9 ASN A 570 TRP A 622 LYS A 625 SER A 626 SITE 2 AC3 9 LYS A 629 VAL A 791 GLN A 792 ILE A 793 SITE 3 AC3 9 EDO A1806 SITE 1 AC4 5 GLN A 541 CYS A 604 GLY A 605 ASN A 606 SITE 2 AC4 5 AU5 A1795 SITE 1 AC5 4 TYR A 525 TYR A 550 VAL A 601 HOH A2057 SITE 1 AC6 6 ASP A 595 HIS A 636 HIS A 639 ILE A 782 SITE 2 AC6 6 EDO A1803 HOH A2056 SITE 1 AC7 4 ASN A 570 TYR A 574 GLN A 794 HOH A2058 SITE 1 AC8 4 ILE A 549 TYR A 589 CYS A 604 HOH A2006 SITE 1 AC9 4 THR A 594 ASP A 595 GLN A 596 EDO A1800 SITE 1 BC1 4 PRO A 760 GLU A 761 LYS A 762 ASP A 763 SITE 1 BC2 2 ARG A 774 ASP A 775 SITE 1 BC3 3 ASP A 566 GLN A 792 P4C A1797 SITE 1 BC4 5 ASN A 562 ASP A 566 ARG A 569 GLU A 633 SITE 2 BC4 5 EDO A1811 SITE 1 BC5 3 LEU A 613 LYS A 617 HOH A2049 SITE 1 BC6 3 ILE A 738 ASN A 739 SER A 742 SITE 1 BC7 4 TYR A 574 HIS A 641 ILE A 793 GLN A 794 SITE 1 BC8 5 HIS A 636 THR A 637 GLN A 640 EDO A1807 SITE 2 BC8 5 HOH A2016 SITE 1 BC9 4 TRP A 622 GLU A 623 SER A 626 GLY A 658 CRYST1 70.930 111.960 113.090 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014098 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008932 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008843 0.00000